William S. Hancock Award for Outstanding Achievements in CMC Regulatory Science
The Hancock Award recognizes outstanding and sustained contributions to the field of CMC regulatory science. Past recipients have been instrumental in enabling the availability of high-quality life-saving medicines derived from recombinant technology on a global basis.
Nominate
The Vice President of the Board is designated as chair of the selection committee. Annually, he or she will select three board members to serve for that year. The committee will nominate individuals that meet the award citation requirements, and subsequently make a (unanimous) selection for endorsement by the CASSS Board by September of each year.
If you would like to nominate an individual, please contact info@casss.org.
Eligibility
Eligible nominee's achievements should include significant contributions to the advancement of scientific principles, applied technologies, and/or science-based regulations in the areas of manufacturing process, technology development, characterization, analysis, and quality of biotechnology-derived pharmaceuticals.
Current members of the CASSS Board of Directors are not eligible for nomination.
2024 William S. Hancock Award Recipient
CASSS has honored Wassim
Nashabeh, PhD with its prestigious William S. Hancock Award for Outstanding Achievement in CMC Regulatory Science. Nashabeh was announced as the
2024 honoree during the Symposium on the Interface of Regulatory and Analytical Sciences for Biotechnology Health Products (WCBP), held in Washington D.C. on January 23-25.
Read more about Nashabeh and his achievements here.